Cardiac arrhythmias in congestive heart failure

Expert Review of Cardiovascular Therapy

Volumn 8, Issue 2, 2010, Pages 137-140

  Kantharia, Bharat K ^a,b,c  

^a UNIVERSITY OF TEXAS   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c MEMORIAL HERMANN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; DOFETILIDE; DRONEDARONE; NORADRENALIN; PLACEBO; SODIUM CALCIUM EXCHANGE PROTEIN; ANTIARRHYTHMIC AGENT;

AGING; CARDIAC RESYNCHRONIZATION THERAPY; CONGESTIVE HEART FAILURE; COST EFFECTIVENESS ANALYSIS; DEFIBRILLATOR; DRUG FATALITY; EDITORIAL; HEART ARRHYTHMIA; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; MITRAL VALVE REGURGITATION; POTASSIUM CURRENT; RISK BENEFIT ANALYSIS; SURVIVAL RATE; ABLATION THERAPY; DRUG CONTRAINDICATION; HEART FAILURE; PATHOPHYSIOLOGY; SUDDEN DEATH;

ABLATION TECHNIQUES; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HEART FAILURE; HUMANS;

EID: 77951929621     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/erc.09.185     Document Type: Editorial

References (32)

1. Hunt SA, Abraham WT, Chin MH et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 119(14), e391-e479 (2009).
2. Dickstein K, Cohen-Solal A, Filippatos G et al. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur. Heart J. 29, 2388-2442 (2008).
3. Roger VL, Weston SA, Redfield MM et al. Trends in heart failure incidence and survival in a community-based population. JAMA 21, 292(3), 344-350 (2004).
4. Schocken DD, Benjamin EJ, Fonarow GC et al. Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group. Circulation 117, 2544-2565 (2008).
5. Francis GS. Development of arrhythmias in the patients with congestive heart failure: pathophysiology, prevalence and prognosis. Am. J. Cardiol. 57, 3B-7B (1986).
6. Podrid PJ, Fogel RI, Fuchs TT. Ventricular arrhythmia in congestive heart failure. Am. J. Cardiol. 69, 82G-96G (1992).
7. Singh SN, Fisher SG, Carson PE, Fletcher RD; Department of Veterans Affairs CHF STAT Investigators. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. J. Am. Col. Cardiol. 32, 942-947 (1998).
8. Cleland JGF, Swedberg K, Follath F et al.; Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur. Heart J. 24, 442-463 (2003).
9. Rivero-Ayerza M, Reimer WS, Lenzen M et al. New-onset atrial fibrillation is an independent predictor of in-hospital mortality in hospitalized heart failure patients: results of the EuroHeart Failure Survey. Eur. Heart J. 29, 1618-1624 (2008).
10. Benjamin EJ, Levy D, Vaziri SM et al. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 271, 840-844 (1994).
11. Sartiani L, Stillitano F, Cerbai E, Mugelli A. Electrophysioilogic changes in heart failure: focus on pacemaker channels. Can. J. Physiol. Pharmacol. 87, 84-90 (2009).
12. Weiss JN, Qu Z. Molecular and cellular basis of arrhythmias in heart failure. In: Atlas of Electrophysiology in Heart Failure. Shivkumar K, Wesis JN, Fonarow GC, Naula J, Braunwald E (Eds). Current Medicine LLC, PA, USA (2005).
13. Yano M. Ryanodine receptor as a new therapeutic target of heart failure and lethal arrhythmia. Circ. J. 72, 509-514 (2008).
14. Tomaselli GF, Zipes DP. What causes sudden death in heart failure? Circ. Res. 95, 754-763 (2004).
15. Frenneaux MP. Autonomic changes in patients with heart failure and in post-myocardial infarction patients. Heart 90, 1248-1255 (2004).
16. Makkar KM, Sanoski CA, Spinlen SA. Role of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and aldosterone antagonist in the prevention of atrial and ventricular arrhythmias. Pharmacotherapy 29(1), 31-48 (2009).
17. Wanwarang W, Chen SA. Management of atrial fibrillation in patients with heart failure; from drug therapy to ablation. Expert Rev. Cardiovasc. Ther. 7(3), 311-322 (2009).
18. Patel D, Natale A, Di Biase L et al. Catheter ablation for atrial fibrillation: a promising therapy for congestive heart failure. Expert Rev. Cardiovasc. Ther. 7(7), 779-787 (2009).
19. Nayar V, Pugh PJ. Cardiac resynchronization therapy for the treatment of heart failure. Expert Rev. Cardiovasc. Ther. 8(2), 229-239 (2010).
20. Torp-Pedersen C, Møller M, Block-Thomsen PE et al.; The Danish Investigations of Arrhythmia and Mortality on Dofetilide Study Group. Dofetilide in patients with congestive heart failure and left ventricular dysfunction. N. Engl. J. Med. 341, 857-865 (1999).
21. Doval HC, Nul DR, Grancelli HO et al.; Grupo de Estudio de la Sobrevida en la Insuficiencia Cardiaca en Argentina (GESICA). Randomised trial of low-dose amiodarone in severe congestive heart failure. Lancet 344, 493-498 (1994).
22. Singh SN, Fletcher RD, Fisher SG et al. The survival trial of antiarrhythmic therapy in congestive heart failure. N. Engl. J. Med. 333, 77-82 (1995).
23. Bardy GH, Lee KL, Mark DB et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N. Engl. J. Med. 352, 225-237 (2005).
24. Køber L, Torp-Pedersen C, McMurray JJV et al.; Dronedarone Study Group. Increased Mortality after Dronedarone Therapy for Severe Heart Failure. N. Engl. J. Med. 358, 2678-2687 (2008).
25. Roy D, Talajic M, Nattel S et al.; Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N. Engl. J. Med. 358(25), 2667-2677 (2008).
26. Khan MN, Jaïs P, Cummings J et al.; PABA-CHF Investigators. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure. N. Engl. J. Med. 359(17), 1778-1785 (2008).
27. Moss AJ, Hall WJ, Cannom DS et al.; Multicenter Automatic Defibrillator Implantation Trial Investigators. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N. Engl. J. Med. 335, 1933-1940 (1996).
28. Buxton AE, Lee KL, Fisher JD et al. A randomized study of the prevention of sudden death in patients with coronary artery disease. N. Engl. J. Med. 341, 1882-1890 (1999).
29. Moss AJ, Zareba W, Hall WJ et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N. Engl. J. Med. 346, 877-878 (2002).
30. Gold MR, Ip JH, Costantini O et al. Role of microvolt T-wave alternans in assessment of arrhythmia vulnerability among patients with heart failure and systolic dysfunction. Circulation 118, 2022-2028 (2008).
31. Bristow MR, Saxson LA, Boehmer J et al. Cardiac resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med. 350, 2140-2150 (2004).
32. Kantharia BK. Cost-effectiveness aspects of defibrillators: decreasing the financial burden. Cardiol. Manage. 3(1), 13-14 (2009).